跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HADLIMA 40MG/0.8ML INJECTION IN PRE-FILLED SYRING - SFDA Drug Approval Details
Approvals
/
SFDA
/
HADLIMA 40MG/0.8ML INJECTION IN PRE-FILLED SYRING
Authorized
BIOLOGICAL
HADLIMA 40MG/0.8ML INJECTION IN PRE-FILLED SYRING
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
5f8d8c3af9c17108
Company
Unknown
Type
Biological
Approval Details
Approval Id
5f8d8c3af9c17108
Drug Approval Sfda Name
HADLIMA 40MG/0.8ML INJECTION IN PRE-FILLED SYRING
Trade Name
HADLIMA 40MG/0.8ML INJECTION IN PRE-FILLED SYRING
Generic Name
ADALIMUMAB
Register Number
3101221655
Register Year
2022
Drug Type
Biological
Route Of Administration
Subcutaneous use
Package Type
Pre-filled syringe
Package Size
2
Size
0.8
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
Store in a refrigerator (2°C – 8°C), do not freeze
Shelf Life
36 Months
Distribution Site
Pharmacy
Description Code
7000000018-40-100000073863
Price
1889.1
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
5f8d8c3af9c17108
Type
Biological
Back to SFDA Approvals
